Telix Pharmaceuticals (TLX) Shares Outstanding (2023 - 2026)

Telix Pharmaceuticals (TLX) has reported Shares Outstanding (Entity) for 2 consecutive years, with $331.2 million the latest figure, recorded in Q4 2024.

• In Q4 2024, Shares Outstanding (Entity) rose 3.77% year-over-year to $331.2 million; the TTM figure through Dec 2024 stood at $331.2 million (up 3.77% YoY), while the FY2024 annual figure was $331.2 million, up 3.77% from the prior year.
• Shares Outstanding (Entity) improved to $331.2 million in Q4 2024 per TLX's latest filing, from $319.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $331.2 million in Q4 2024 and bottomed at $319.2 million in Q4 2023.